Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort. - Rha SY; Castanon E; Gill S; Senellart H; Lopez J; Márquez-Rodas I; Victoria I; Kim TM; Lwin Z; Burger MC; Simonelli M; Cassier PA; et al. (Cancer, 2025)